ASSESSING GASTRIC MUCOSAL CHANGES IN CHRONIC NSAID USERS WITH AND WITHOUT GASTROPROTECTIVE THERAPY IN COMPARISON: A CROSS-SECTIONAL STUDY
DOI:
https://doi.org/10.71000/m2dfp028Keywords:
Anti-Inflammatory Agents, Non-Steroidal, Endoscopy, Gastrointestinal, Gastric Mucosa, Gastrointestinal Diseases, Helicobacter Infections, Proton Pump Inhibitors, Risk FactorsAbstract
Background: Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs) is a major cause of gastric mucosal injury, ranging from gastritis to peptic ulcer disease. Gastroprotective agents such as proton pump inhibitors are widely prescribed to reduce these risks, yet their real-world effectiveness in preserving gastric mucosal integrity remains underexplored, particularly in South Asian populations.
Objective: To evaluate gastric mucosal changes among chronic NSAID users receiving and not receiving gastroprotective therapy.
Methods: A cross-sectional study was conducted in Lahore over five months, including 100 adult participants divided equally between NSAID users with gastroprotective therapy (n=50) and those without (n=50). Inclusion criteria required at least three months of continuous NSAID use. Patients underwent upper gastrointestinal endoscopy, and findings were classified using the Updated Sydney System. Data regarding Helicobacter pylori infection were also collected. Statistical analysis was performed using independent t-tests, chi-square tests, and logistic regression, with p<0.05 considered significant.
Results: The mean age of participants was 49.8 ± 11.2 years in the gastroprotection group and 50.4 ± 10.9 years in the non-protection group. Normal gastric mucosa was observed in 40% of those with gastroprotection compared to 16% without. Erosive gastritis was identified in 18% versus 36%, and peptic ulcer in 10% versus 20% respectively. Severe mucosal lesions were significantly more common in the non-protected group (18%) compared to the gastroprotected group (6%). Logistic regression confirmed that absence of gastroprotective therapy was an independent predictor of mucosal injury after adjusting for confounders.
Conclusion: Gastroprotective therapy substantially reduced the frequency and severity of gastric mucosal injury among chronic NSAID users. These findings support routine incorporation of preventive therapy to minimize NSAID-induced gastropathy.
References
Biase TM, Rocha JG, Silva MT, Ribeiro-Vaz I, Galvão TF. Renal effects of selective cyclooxygenase-2 inhibitor anti-inflammatory drugs: A systematic review and meta-analysis. Exploratory Research in Clinical and Social Pharmacy. 2024 Sep 1;15:100475.
Tai FWD, McAlindon MEJCM. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. 2021;21(2):131-4.
Galos F, Ionescu MI, Mirea MD, Boboc AA, Ioan A, Boboc C. Trends in Upper Gastrointestinal Bleeding in Children: The Impact of Helicobacter pylori Infection and Non-Steroidal Anti-Inflammatory Drug Use. Antibiotics. 2024 Aug 10;13(8):752.
Zhang X, Xiao X, Chen PR, Li YN, Lv XH, Yang JL. Proton pump inhibitors increase the risk of nonsteroidal anti-inflammatory drug-related small-bowel injury: a systematic review with meta-analysis. Clinical and Translational Gastroenterology. 2023 Jun 1;14(6):e00588.
Zhang X, Xiao X, Chen PR, Li YN, Lv XH, Yang JL. Proton pump inhibitors increase the risk of nonsteroidal anti-inflammatory drug-related small-bowel injury: a systematic review with meta-analysis. Clinical and Translational Gastroenterology. 2023 Jun 1;14(6):e00588.
Halvey EJ, Haslam N, Mariano ER. Non-steroidal anti-inflammatory drugs in the perioperative period. BJA education. 2023 Nov 1;23(11):440-7.
Zhang X, Xiao X, Chen PR, Li YN, Lv XH, Yang JL. Proton pump inhibitors increase the risk of nonsteroidal anti-inflammatory drug-related small-bowel injury: a systematic review with meta-analysis. Clinical and Translational Gastroenterology. 2023 Jun 1;14(6):e00588.
Zhang X, Xiao X, Chen PR, Li YN, Lv XH, Yang JL. Proton pump inhibitors increase the risk of nonsteroidal anti-inflammatory drug-related small-bowel injury: a systematic review with meta-analysis. Clinical and Translational Gastroenterology. 2023 Jun 1;14(6):e00588.
Jung YS, Park JH, Park CHJUEGJ. Impact of proton pump inhibitors on the risk of small bowel or colorectal bleeding: A systematic review and meta‐analysis. 2023;11(9):861-73.
Lee M, Kim M, Cha JM. Risk of Lower Gastrointestinal Bleeding in Nonsteroidal Anti-inflammatory Drug (NSAID) and Proton Pump Inhibitor Users Compared with NSAID-Only Users: A Common Data Model Analysis. Gut and Liver. 2025 Jan 3;19(2):243.
Zhang X, Xiao X, Chen P-R, Li Y-N, Lv X-H, Yang J-LJC, et al. Proton pump inhibitors increase the risk of nonsteroidal anti-inflammatory drug-related small-bowel injury: a systematic review with meta-analysis. 2023;14(6):e00588.
Andrawes M, Andrawes W, Das A, Siau K. Proton Pump Inhibitors (PPIs)—An Evidence-Based Review of Indications, Efficacy, Harms, and Deprescribing. Medicina. 2025 Aug 31;61(9):1569.
Kumar SS, Arvind S, Umpierrez APJJoHM. Things We Do for No Reason™: Routine use of proton pump inhibitors for peptic ulcer prophylaxis in adults on high‐dose corticosteroids. 2023;18(7):630-2.
Zhang X, Xiao X, Chen PR, Li YN, Lv XH, Yang JL. Proton pump inhibitors increase the risk of nonsteroidal anti-inflammatory drug-related small-bowel injury: a systematic review with meta-analysis. Clinical and Translational Gastroenterology. 2023 Jun 1;14(6):e00588.
Farrell B, Lass E, Moayyedi P, Ward D, Thompson W. Reduce unnecessary use of proton pump inhibitors. Bmj. 2022 Oct 24;379.
Kadam P, Tiwari S, Daswani B, Taware A, Hiray R. Pharmacoeconomics and Utilization of Intravenous Proton Pump Inhibitors in a Tertiary Care Hospital. Journal of Pharmaceutical Care. 2022 Oct 3.
Dyomin EP. Prevention of Gastroduodenopathy Induced by the use of Nonsteroidal Anti-Inflammatory Drugs in Patients with Osteoarthritis of the Knee Joints with Eupatiline. Медицина. 2021 Dec 15;225(3):28-35.
Thurber KM, Otto AO, Stricker SL. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use. American Journal of Health-System Pharmacy. 2023 Apr 15;80(8):487-94.
Zeng C, Doherty M, Persson MS, Yang Z, Sarmanova A, Zhang Y, Wei J, Kaur J, Li X, Lei G, Zhang W. Comparative efficacy and safety of acetaminophen, topical and oral non-steroidal anti-inflammatory drugs for knee osteoarthritis: evidence from a network meta-analysis of randomized controlled trials and real-world data. Osteoarthritis and Cartilage. 2021 Sep 1;29(9):1242-51.
Thurber KM, Otto AO, Stricker SL. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use. American Journal of Health-System Pharmacy. 2023 Apr 15;80(8):487-94.
Thurber KM, Otto AO, Stricker SLJAJoH-SP. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use. 2023;80(8):487-94.
Dharmarajan TS. The use and misuse of proton pump inhibitors: an opportunity for deprescribing. Journal of the American Medical Directors Association. 2021 Jan 1;22(1):15-22.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sawera Tahir, Muhammad Hassan Laique, Offisa Kausar, M Arslan Liaqat, Shahid Ullah, Zarish Patrus, Abdul Wahab Ali (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
